Rentschler Biopharma SE
Laupheim
About Rentschler Biopharma SE
What unites us at Rentschler, is the passion for what they do. As a full-service CDMO they are your outsourcing partner for the bioprocess development, cGMP manufacturing and aseptic filling of biopharmaceuticals as well as for the elaboration of approval strategies for your products. Thanks to their many years of experience, the quality of their consulting services, and their expertise in finding solutions, they are among the top suppliers in their field. Founded in 1927, Rentschler is a privately owned and independent company. Their company structure guarantees rapid decision-making and efficient, smooth-running processes, and consequently keeping project timelines. Already in the early beginnings of biotechnology, Rentschler has built up a reputation with the development of different Interferon products (Fiblaferon, Polyferon). Nowadays, their attention is firmly focused on your products. For the success of your project they can refer to their experience in various molecules like antibodies, fusion proteins or enzymes. Thanks to their focus on innovations, they are always on the cutting edge of technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: Less than $1M
- Total funding: $1.6M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2016)
- Website: rentschler-biopharma.com
- Phone: (497)392-7010
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/rentschler-biopharma-se-54397 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.